The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EORTC CLTF 2021 | Measuring CTCs in CTCL
Maarten Vermeer
• 15 Oct 2021
Maarten Vermeer, MD, PhD, Leiden University Medical Center, Leiden, Netherlands, discusses novel methods to identify and quantify circulating tumor cells (CTCs) in patients with cutaneous T-cell lymphoma (CTCL), commenting on the role of markers in detecting cell surface protein heterogeneity. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
